IRTCiRhythm Technologies Inc

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm PR Newswire NEW YORK, July 2, 2026 NEW YORK, July 2, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap PR Newswire TORONTO, ON, June 16, 2026 Issued on behalf of Ventripoint Diagnostics Ltd.As the number of...

iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains...

The consensus price target hints at a 57.2% upside potential for IRHYTHM HLDGS (IRTC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Comerica Bank cut its stake in shares of iRhythm Technologies (NASDAQ:IRTC - Free Report) by 47.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and...

Citigroup increased their price objective on shares of iRhythm Technologies from $155.00 to $157.00 and gave the company a "buy" rating in a report on Monday...

iRhythm narrows Q1 losses, lifts 2026 outlook and posts 25.7% revenue growth as strong demand and margin gains drive momentum.

Shares of iRhythm Technologies (NASDAQ:IRTC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fifteen ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating...